Microcomputed tomographic and histologic analysis of anorganic bone matrix coupled with cell-binding peptide suspended in sodium hyaluronate carrier after sinus augmentation: A clinical study

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue 3, 2011, Pages 561-570

  Emam, Hany ^a,b   Beheiri, Galal ^b   Elsalanty, Mohammed ^a   Sharawy, Mohamed ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Anorganic bone matrix; Cell binding peptide; Microcomputed tomography; Sinus augmentation

Indexed keywords

BIOMATERIAL; CELL BINDING PEPTIDE P 15; CELL-BINDING PEPTIDE P-15; COLLAGEN; DRUG CARRIER; HYALURONIC ACID; HYDROXYAPATITE; PEPTIDE FRAGMENT;

ADULT; ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; BONE MATRIX; BONE PROSTHESIS; BONE REGENERATION; CATTLE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; GEL; HISTOLOGY; HUMAN; MALE; MAXILLA; MAXILLARY SINUS; METHODOLOGY; MICRO-COMPUTED TOMOGRAPHY; MIDDLE AGED; NONPARAMETRIC TEST; ORAL SURGERY; OSTEOLYSIS; RADIOGRAPHY; TOOTH IMPLANTATION; TRANSPLANTATION;

ABSORBABLE IMPLANTS; ADULT; ALVEOLAR BONE LOSS; ALVEOLAR RIDGE AUGMENTATION; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MATRIX; BONE REGENERATION; BONE RESORPTION; BONE SUBSTITUTES; CATTLE; COLLAGEN; DENTAL IMPLANTATION, ENDOSSEOUS; DRUG CARRIERS; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; HYALURONIC ACID; HYDROXYAPATITES; MALE; MAXILLA; MAXILLARY SINUS; MIDDLE AGED; ORAL SURGICAL PROCEDURES, PREPROSTHETIC; OSSEOINTEGRATION; PEPTIDE FRAGMENTS; STATISTICS, NONPARAMETRIC; X-RAY MICROTOMOGRAPHY;

EID: 84862807536     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Chiapasco M, Zaniboni M, Rimondini L. Dental implants placed in grafted maxillary sinuses: A retrospective analysis of clinical outcome according to the initial clinical situation and a proposal of defect classification. Clin Oral Implants Res 2008;19:416-428.
2. Misch CE, Dietsch F. Bone-grafting materials in implant dentistry. Implant Dent 1993;2:158-167.
3. Cordioli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. Maxillary sinus floor augmentation using bioactive glass granules and autogenous bone with simultaneous implant placement. Clinical and histological findings. Clin Oral Implants Res 2001;12:270-278.
4. Yang XB, Bhatnagar RS, Li S, Oreffo RO. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 2004;10:1148-1159.
5. Bhatnagar RS, Qian JJ, Gough CA. The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1 (I) chain: Structural and biological evidence for conformational tautomerism on fiber surface. J Biomol Struct Dyn 1997;14:547-560.
6. Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 1999;5:53-65.
7. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun 2003;311:179-186.
8. Neiva RF, Tsao YP, Eber R, Shotwell J, Billy E, Wang HL. Effects of a putty-form hydroxyapatite matrix combined with the synthetic cell-binding peptide P-15 on alveolar ridge preservation. J Periodontol 2008;79:291-299.
9. Laurent TC. Biochemistry of hyaluronan. Acta Otolaryngol Suppl 1987;442:7-24.
10. Kuhn JL, Goldstein SA, Feldkamp LA, Goulet RW, Jesion G. Evaluation of a microcomputed tomography system to study trabecular bone structure. J Orthop Res 1990;8:833-842.
11. Misch C. Bone density: A key determinant for treatment planning. In: Misch C. Contemporary Implant Dentistry, ed 3. St Louis: Mosby Elsevier, 2008:130-146.
12. Woo I, Le BT. Maxillary sinus floor elevation: Review of anatomy and two techniques. Implant Dent 2004;13:28-32.
13. Schwartz Z, Goldstein M, Raviv E, Hirsch A, Ranly DM, Boyan BD. Clinical evaluation of demineralized bone allograft in a hyaluronic acid carrier for sinus lift augmentation in humans:A computed tomography and histomorphometric study. Clin Oral Implants Res 2007;18:204-211.
14. Choi KS, Kan JY, Boyne PJ, Goodacre CJ, Lozada JL, Rungcharassaeng K. The effects of resorbable membrane on human maxillary sinus graft: A pilot study. Int J Oral Maxillofac Implants 2009;24:73-80.
15. Tehemar S, Hanes P, Sharawy M. Enhancement of osseointegration of implants placed into extraction sockets of healthy and periodontally diseased teeth by using graft material, an ePTFE membrane, or a combination. Clin Implant Dent Relat Res 2003;5:193-211.
16. Gelbart M, Friedman R, Burlui V, Rohrer M, Atkinson B. Maxillary sinus augmentation using a peptide-modified graft material in three mixtures: A prospective human case series of histologic and histomorphometric results. Implant Dent 2005;14:185-193.
17. Valentin AH, Weber J. Receptor technology-Cell binding to P-15: A new method of regenerating bone quickly and safely-Preliminary histomorphometrical and mechanical results in sinus floor augmentations. Keio J Med 2004;53:166-171.
18. Eto AL, Joly JC, Jeffcoat M, de Araujo NS, de Araujo VC, Cury PR. Use of anorganic bovine-derived hydroxyapatite matrix/ cell-binding peptide (P-15) in the treatment of class II furcation defects: A clinical and radiographic study in humans. J Periodontol 2007;78:2277-2283.
19. Smiler DG. Comparison of anorganic bovine mineral with and without synthetic peptide in a sinus elevation: A case study. Implant Dent 2001;10:139-142.
20. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999;7:79-89.
21. Huang L, Cheng YY, Koo PL, et al. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarialderived cell cultures. J Biomed Mater Res A 2003;66:880-884.
22. Boskey AL, Dick BL. Hyaluronan interactions with hydroxyapatite do not alter in vitro hydroxyapatite crystal proliferation and growth. Matrix 1991;11:442-446.
23. Zou X, Li H, Chen L, Baatrup A, Bunger C, Lind M. Stimulation of porcine bone marrow stromal cells by hyaluronan, dexamethasone and rhBMP-2. Biomaterials 2004;25:5375-5385.
24. Araujo M, Linder E, Lindhe J. Effect of a xenograft on early bone formation in extraction sockets: An experimental study in dog. Clin Oral Implants Res 2009;20:1-6.
25. Matos SM, Guerra FA, Krauser J, Marques F, Ermida JM, Sanz M. Clinical evaluation of the combination of anorganic bovinederived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study. J Periodontol 2007;78:1855-1863.
26. Yeung RW, Jin LJ, Pang M, Pow E. Human histologic and electromicroscopic analysis with synthetic peptide enhanced hydroxyapatite in the maxillary sinus elevation procedure:A case report. Implant Dent 2005;14:237-241.
27. Wikesjo UM, Huang YH, Polimeni G, Qahash M. Bone morphogenetic proteins: A realistic alternative to bone grafting for alveolar reconstruction. Oral Maxillofac Surg Clin North Am 2007;19:535-551.
28. Trasatti C, Spears R, Gutmann JL, Opperman LA. Increased Tgf-beta1 production by rat osteoblasts in the presence of PepGen P-15 in vitro. J Endod 2004;30:213-217.
29. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 2008;108:18-31.